Seven AI/ML innovators with the potential to accelerate drug discovery and development
Artificial intelligence and machine learning hold tremendous potential to identify new molecules and accelerate drug development to deliver innovative medicines to patients faster. Clarivate analysts identified seven promising early-stage companies working on AI and machine learning applications for drug discovery and development and identified critical best practices and trends in this emerging technology, including:
Download the report to learn more about the trends shaping this fast-moving space and which AI/ML companies are ones to watch.
Got questions? To speak with one of our market specialists, please contact us here.